LD-1

FDA 510(k) K981338 · Abbott Laboratories

Substantially Equivalent

510(k) numberK981338

Submission

Device name
LD-1
Applicant
Abbott Laboratories
Irving, TX, US
Received
April 13, 1998
Decision date
May 18, 1998
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
JGF – Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes
Device class
Class II (moderate risk)
Regulation
21 CFR 862.1445
Specialty
Clinical Chemistry

Other 510(k)s with product code JGF

510(k)DeviceApplicantDecision
K925188Abbott Quickstart LD-1, ModificationJGF · Traditional Em Diagnostic Systems, Inc.02/05/1993SE
K914261Abbott Quickstart LD-1,#5A30JGF · Traditional Em Diagnostic Systems, Inc.10/21/1991SE
K890996LD1 Isoenzyme Reagent KitJGF · Traditional Trace Scientific , Ltd.05/05/1989SE
K871240Abbott A-Gent LD-1 Isozyme ReagentJGF · Traditional Abbott Laboratories05/13/1987SE
K860367Magnesium (Substrate, Enzyme, Reagent)JGF · Traditional Alpkem Corp.04/11/1986SE

More from Alpkem Corp.

510(k)DeviceDecision
K252424Anti-HCV NextMZO · Traditional 04/28/2026SE
K243500ARCHITECT iGentamicinLCD · Special 07/09/2025SE
K243168Alinity i Rubella IgGLFX · Traditional 06/20/2025SE
K243283Alinity h-series SystemGKZ · Traditional 02/20/2025SE
K233932Alinity i Toxo IgMLGD · Traditional 08/30/2024SE
K232669TbiQAT · Special 09/29/2023SE
K222850HAVAb IgG IILOL · Traditional 08/10/2023SE
K220031Alinity h-series SystemGKZ · Traditional 08/04/2023SE
K220282i-STAT PTplus Cartridge with the i-STAT 1 SystemGJS · Traditional 07/14/2023SE
K230937Alinity i Total ß-hCG Reagent Kit, GLP systems TrackDHA · Traditional 06/05/2023SE

Questions and answers

When was LD-1 cleared by the FDA?

LD-1 (K981338) received a 510(k) decision of Substantially Equivalent on May 18, 1998, 35 days after the submission was received.

What is the product code of K981338?

The FDA product code is JGF – Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes, a Class II (moderate risk) device regulated under 21 CFR 862.1445.